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Central arterial systolic blood pressure (SBP) and arterial stiffness are known to be better 22 
predictors of adverse cardiovascular outcomes than brachial SBP. The effect of progressive 23 
high altitude (HA) on these parameters has not been examined.  24 
Ninety healthy adults were included. Central BP and the augmentation index (AI) were 25 
measured at the level of the brachial artery (Uscom BP+ device) at <200m and at 3619m, 26 
4600m and 5140m. The average age of the subjects (70% men) were 32.2±8.7 years. 27 
Compared with central arterial pressures, brachial SBP (+8.1±6.4 mmHg; p<0.0001) and 28 
pulse pressure (+10.9±6.6 mmHg; p<0.0001) were significantly higher and brachial DBP 29 
was lower (-2.8±1.6 mmHg; P<0.0001). Compared <200m, HA led to a significant 30 
increase in brachial and central SBP. Central SBP correlated with AI (r=0.50; 95% CI: 31 
0.41 to 0.58: p<0.0001) and age (r=0.32; 21to 0.41: p<0.001). AI positively correlated with 32 
age (r=0.39; p<0.001) and inversely with subject height (r=-0.22; p<0.0001) weight (r=-33 
0.19; p=0.006) and heart rate (r=-0.49: p<0.0001). There was no relationship between 34 
acute mountain sickness scores (LLS) and AI or central BP. The independent predictors of 35 
central SBP were male sex (coefficient, t 4.7; P<0.0001), age (t=3.6; p=0.004) and AI 36 
(t=7.5; p<0.0001; overall r2 =0.40; p<0.0001). Subject height (t=2.4; p=0.02), age (7.4; 37 
p<0.0001) and heart rate (t=11.4; P<0.0001) were the only independent predictors of AI 38 
(overall r2=0.43; p<0.0001). Central BP and AI significantly increase at HA. This rise was 39 
influenced by subject-related factors and heart rate but not independently by altitude, LLS 40 
or SpO2.   41 
 42 
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Introduction  44 
Cardiovascular death is a leading cause of non-traumatic deaths in adults at high altitude 45 
(HA).1 Despite this fact, there has been limited research into cardiovascular risk 46 
assessment at HA. 1 HA exposure leads to an increase in resting heart rate, compared with 47 
that at sea level, yet paradoxically, maximal heart rate is reduced.2   The stroke volume rise 48 
noted with exercise at sea level is blunted at HA.2,4 Consequently, whilst resting cardiac 49 
output is higher at HA, versus sea level, at peak exercise it is comparatively lower.2,4,5 50 
These factors along with the notable reduction in arterial oxygen content act to limit peak 51 
exercise capacity and oxygen consumption.2,5 Other reported cardiovascular responses 52 
include an increase in resting brachial artery systolic blood pressure (SBP) and 24hour 53 
arterial blood pressure (BP), which along with the increase in resting heart rate could be 54 
potential implicating factors in the increased cardiovascular risk.6-9    55 
The effects of HA on central arterial haemodynamics, such as central arterial BP and large 56 
artery stiffness, are far less well understood and have been barely reported. Central arterial 57 
BP and large artery stiffness are known to be more powerful predictors of adverse 58 
cardiovascular outcomes, including stroke and cardiovascular death than brachial artery BP 59 
as they more closely reflect the haemodynamic loading of vital central organs such as the 60 
heart, brain and kidneys.10.11 Brachial artery BP does not reliably reflect central BP due to 61 
the effects of peripheral amplification which is highly variable between individuals.10,11      62 
 Unfortunately, the accurate non-invasive assessment of central BP and large artery 63 
stiffness has been traditionally very difficult. It had required the need for either arterial 64 
catheterisation or less portable and expensive non-invasive equipment limiting its research 65 
utility at HA, explaining the paucity of published research at genuine terrestrial HA.5.7  66 
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In the only study to investigate the influence of terrestrial HA on both large arterial 67 
stiffness and central BP Parati et al observed a significant increase in both central SBP and 68 
the arterial augmentation index (AI, marker of arterial stiffness) in untreated subjects 69 
travelling to HA.7 However, the altitude gain was very rapid (4559m within 28 hours of 70 
ascent) and only a single altitude was studied. Nevertheless, their findings are potentially 71 
important given the huge numbers exposed to HA worldwide.1,2  72 
The Uscom BP+ is a novel device which is able to estimate central blood pressure 73 
using a simple oscillometric BP cuff on the upper arm.12 It has shown excellent agreement 74 
with catheter based assessments of central BP and gold standard measures of arterial 75 
stiffness.1315 It utilises pulse wave analysis to assess the AI which reflects the enhancement 76 
(augmentation) of central aortic systolic pressure by reflected arterial pulse waves. It has 77 
the advantage over several competing devices. It is highly portable and only requires the 78 
use of an upper arm cuff therefore avoiding the need to assess either the radial or digital 79 
pulse where the signal to noise ratio may be less favourable.   80 
In this study we sought to utilise this available technology to investigate, for the 81 
first time the effects of a step-wise increasing terrestrial HA on both central BP and AI 82 
during a trek to >5000m.  83 
  84 
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Methods 85 
Study design and participants 86 
Ninety healthy British Military servicemen aged >18years were included. Inclusion was 87 
entirely voluntary and represented a large subset of military servicemen who had been 88 
selected to take part in a quadrennial military adventure training exercise to HA. 89 
Significant mountaineering experience was not essential but those with very limited 90 
experience were encouraged to attend a winter skills course (<1200m) within 3 months of 91 
departure. The subjects were assessed at near sea level (<200m) and during progressive 92 
ascent in the Dhaulagiri region in the Himalayas in March/April 2016. Health status was 93 
confirmed following a detailed baseline questionnaire. All subjects were assessed to be 94 
medically fit for a high altitude venture by their general practitioner. To be considered fit 95 
they were all required to have passed their annual military basic fitness test which includes 96 
a 1.5 mile timed run.  Key exclusion criteria included a history of hypertension and/ or 97 
atrial fibrillation. All participants were low altitude dwellers and none had prior exposure 98 
to >1400m terrestrial altitude in the four weeks prior to this study. The subjects were 99 
studied consecutively in groups of 8-10 individuals with a two day stagger between 100 
successive groups.  HA related symptoms were assessed using the Lake Louis Scoring 101 
System (LLS).16,17  102 
 103 
High Altitude Ascent and descent profile 104 
The subjects flew from the UK to Kathmandu (1400m day 1-3) where they underwent a 105 
short period of local acclimatisation at 1400m. From there they travelled by a staged road 106 
move to Darbang (1030m) then on foot with loads of up to 12kg over the ensuing 11 days 107 
to HA of 5140m (after passing over French pas at 5360m) (figure 1). From there they 108 
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commenced trekking on foot over the ensuing 11 days (to day 14) to an altitude of 5140m 109 
(with an overpass of 5360m) before commencing their decent (day 15) on foot to Marpha 110 
(2719m) and then by road back to Kathmandu. Research assessments were performed at 111 
sea level and at static research camps at 3619m (day 9), 4600m (day 12) and 5140m (day 112 
14) during ascent.  113 
 114 
Physiological assessments and central blood pressure measurement 115 
Oxygen saturations (SpO2) were measured using a Nonin Onyx (Nonin Medical Inc, 116 
Plymouth, Minnesota, USA) pulse oximeter.  Blood pressure and arterial stiffness 117 
assessments were obtained at the same time using an Uscom BP+ device (Uscom, Sydney, 118 
NSW, Australia) as previously reported.13-15 The upper arm cuff was attached to the 119 
dominant arm of seated subjects. All subjects were rested for at least five minutes prior to 120 
BP assessment and they were not permitted to drink caffeine or smoke for at least three 121 
hours and alcohol for >10 hours prior to BP measurements.18  The subjects were advised 122 
not to speak during the recordings. The BP+ device measures both central and peripheral 123 
BP (mmHg) using supra systolic oscillometry.  Following an initial inflation-deflation the 124 
cuff is re-inflated to approximately >30mm Hg above the recorded suprasystolic pressure 125 
for 10 seconds, during which suprasystolic BP and pulse wave assessments are recorded 126 
via the arm cuff.  All recordings were stored on a mini SD card within the device and later 127 
exported for data analysis.  Only readings with a signal-to-noise ratio of ≥6 was were 128 
included and tests with a ratio of <6 were repeated.  129 
The BP+ calculates a number of additional haemodynamic indices that were of 130 
interest to this study, including the AI. Its quoted AI is the arterial augmentation pressure 131 
(difference between the second and first systolic peaks of the central pressure waveform) 132 
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expressed as a percentage of the pulse pressure and it is an indirect measure of large 133 
arterial stiffness. Further parameters that we were specifically interested in for this study 134 
were the time to systolic wave Reflection (TR) and the suprasystolic pulse pressure 135 
variation (ssPPV). The reflected Wave Transit Time is an indirect measure of pulse wave 136 
velocity and large arterial stiffness. The ssPPV is a novel measure of fluid responsiveness 137 
and is heavily influenced by respiratory variation and left ventricular stroke volume, both 138 
of which can be affected at HA.19-21   The BP+ calculates the ssPPV as the difference 139 
between maximum and minimum pulse pressures divided by the average pulse pressure 140 
over the 10 second rhythm strip.  141 
 142 
Ethics 143 
Participation was entirely voluntary and all participants underwent detailed written 144 
informed consent.  The study was approved by the Ministry of Defence Research and 145 
Medical Ethics Committee (MODREC) and was conducted according to the standards of 146 
the declaration of Helsinki.  147 
 148 
Statistical analysis  149 
Data were analysed using GraphPad InStat version 3.05 and with all graphical figures 150 
presented using GraphPad Prism version 4.00 for Windows (GraphPad Software, San 151 
Diego, CA, USA). Sample size calculations were performed using a proprietary 152 
determined sample- size calculator using (GraphPad StatMate version 2.00 for Windows). 153 
The Kolmogorov-Smirnov test was undertaken to assess normality of all continuous data 154 
and all continuous data are presented as mean ± standard deviations and median ± 155 
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interquartile range for parametric and non-parametric data respectively. Comparison of 156 
unpaired data was performed using an unpaired T test or the Mann-Whitney Test for 157 
parametric and non-parametric data respectively and with a paired t test and Wilcoxon 158 
matched pairs test for equivalent paired data.  Continuous data from >3 groups were 159 
compared using a one-way Analysis of Variance (ANOVA) with either Tukey post-hoc 160 
tests or a Kruskal-Wallis test with Dunn post-test  for parametric and  non-parametric data 161 
respectively. Correlations were performed using Pearson and Spearman rank correlation 162 
(±95% confidence interval, CI) for parametric and non-parametric data respectively.  A 163 
two tailed P value <0.05 was considered statistically significant for all comparisons. All 164 
univariate predictors of central arterial systolic blood pressure were entered into a multiple 165 
linear regression analysis model in order to identify its independent predictors. A two 166 
tailed P value <0.05 was considered statistically significant for all comparisons.  167 
Sample size calculations  168 
Parati et al studied 44 subjects who travelled form sea level to 4559m within 29 hours.8 169 
From this group there were 22 subjects who were randomised not to receive prophylactic 170 
medication to prevent acute mountain sickness. In this group they observed a non-171 
significant increase in central systolic blood pressure from 103.7±10.7 to 108.8±8.0 mmHg 172 
from sea level to that after 48h at HA. The AI significantly increased at HA versus sea 173 
level. Based on this data and the average standard deviation of their central BP readings, 174 
we calculated that a sample size of at least 60 subjects would have >80% power to detect a >5 175 
mmHg change in central SBP and a >7% change in AI at HA at a significance level (alpha) 176 
of 0.05 (two-tailed). 177 
 178 
Results 179 
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Ninety subjects were included. The average age of the subjects were 32.2±8.7 years with 180 
70% being male. Heart rate and LLS increased and SpO2 fell at HA compared with sea 181 
level (table 1). The average 1.5 mile run time for included subjects was 9.9±1.2 minutes. 182 
Overall brachial arterial SBP (+8.4 [5.0 to 12.0] mmHg; p<0.0001) and pulse 183 
pressure (+11 [7.0 to 15.0] mmHg; p<0.0001) were significantly greater than that observed 184 
centrally. Conversely the brachial artery DBP was lower (-2.6 [-3.4 to -2.0] mmHg; 185 
P<0.0001) than the equivalent central readings.   186 
 Compared with baseline sea level values there was a significant increase in both 187 
brachial and central SBP and in brachial but not central arterial pulse pressure at HA (table 188 
2). The highest increase in both brachial and central SBP was between sea level and 4619m 189 
(+7.0 [-5.0 to 16.0] and +7.0 [-4.5 to 18.0] mmHg respectively) (table 2; figure 2).  190 
 The AI and ssPPV both increased at HA whereas the reflected wave transit time 191 
and systolic ejection period decreased versus sea level (table 2; figure 3). Adjusting the AI 192 
to an average heart rate of 75 per minute (AI@75) did not alter the findings.  193 
There were significant correlations between central SBP and both AI (r=0.50; 0.41 194 
to 0.58: p<0.0001) and age (r=0.32; 21to 0.41: p<0.001). Other independent, albeit weak 195 
predictors, of central SBP were SpO2 (r=-0.14 -0.25 to -0.05: p=0.02),  heart rate (r=-0.16; 196 
-0.27 to -0.05: p=.003) male sex (r =0.15; 046 to 0.26: p=0.004) ethnicity (r=0.15; 0.04 to 197 
0.25: p=0.007) smoking status (r=0.18; -0.28 to -0.07; p=0.001) and altitude (r=0.10; 198 
p=0.05).  AI positively correlated with age (r=0.39; p<0.001) and inversely with subject 199 
height (r-0.22; p<0.0001) weight (r-0.19; p=0.006), and heart rate (-0.49: p<0.0001). There 200 
was no relationship between LLS and either AI or central BP.  201 
Multivariate analysis was performed to assess the independent predictors of central 202 
systolic BP. Only the univariate predictors were included in the model. The independent 203 
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predictors of central SBP were male sex (coefficient, t 4.7; P<0.0001), age (t 3.6; p=0.004) 204 
and AI (t 7.5; p<0.0001; overall r2 =0.40; p<0.0001). If AI was removed from the model 205 
(overall r2=0.29; p<0.0001) then the independent predictors of central systolic BP were 206 
age, heart rate and smoking history.  Subject height (coefficient 2.4; p=0.02), age (7.4; 207 
p<0.0001) and heart rate (11.4; P<0.0001) were the only independent predictors of AI 208 
(overall r2=0.43; p<0.0001). The order of the trekking groups did not influence the findings 209 
when included in the multivariate analysis.  210 
 211 
Discussion 212 
To the author’s knowledge, this is the first study to assess the effects of stepwise increasing 213 
terrestrial HA on arterial stiffness and central BP over a conventional and progressive HA 214 
trek. We found that HA exposure led to a significant increase in central SBP and AI. 215 
Neither altitude nor the SpO2 were independent predictors of AI and central SBP. Heart 216 
rate was a significant determinant of both AI and central BP.  217 
 HA exposure leads to a wide range of complex effects on both the pulmonary and 218 
systolic circulation which have been well described.2,4,5,22 Hypobaric hypoxia leads to 219 
widespread sympathetic activation leading to an increase in resting heart rate .23-25  The 220 
reported effects on BP are variable and are highly dependent on the degree of hypoxia and 221 
speed and duration of exposure.  Furthermore, the type of hypoxic environment may be a 222 
major confounder.26 Several previously published studies have used simulated hypoxia 223 
(using either a normobaric or hypobaric chamber) in an attempt to replicate the degree of 224 
hypoxia observed at genuine HA.4,22,25,26 Whilst they are very useful surrogates for HA 225 
exposure, u simulated hypoxia does not fully reproduce the environmental and 226 
geographical effects genuine terrestrial HA such as the cold or the exercise burden. The 227 
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reported literature has tended to focus on the effects of HA on brachial artery BP and 228 
largely following a relatively short period brief (<6 hours) of simulated hypoxia.22,26 229 
Available data at terrestrial HA has shown that HA exposure typically leads to an increase 230 
in both resting systolic and 24 hour blood pressure which may be more pronounced in 231 
those with background hypertension.9 The effects of HA on central BP and arterial 232 
stiffness have been barely examined at HA, yet they are well recognised to be better 233 
predictors of cardiovascular risk than brachial BP.10,11 Given the vast numbers of patients 234 
with known hypertension and cardiovascular disease who undergo recreational HA 235 
exposure annually the ability to better define cardiovascular risk in these individuals would 236 
be important. This has added importance given that cardiovascular death is a leading cause 237 
of non-traumatic death at HA.1 An improved understanding of the effects of HA on central 238 
BP and other non-invasive measures of cardiovascular risk such as arterial stiffness might 239 
allow for tailored medical therapy at HA to reduce the cardiovascular risk to individuals. 240 
We observed a significant increase in brachial but not central pulse pressure suggesting 241 
differences in BP behaviour in the peripheral versus the central circulation. Indeed whilst 242 
the brachial SBP was higher than that observed centrally the increase  in central SBP was 243 
greater and was significant across all three altitudes studied (table 2).  244 
There has only been one previous study to investigate the effects of HA on 245 
measures of both arterial stiffness and central BP at terrestrial altitude. Parati et al studied 246 
44 subjects who were randomised to placebo or to oral acetazolamide prior to and during 247 
HA exposure.8 Following sea level assessment the subjects ascended to 4559m within 28 248 
hours by road to 1130m, then cable car to 3647m before completing the rest of the ascent 249 
on foot. Measurements at HA were obtained within 4-6 hours of arrival at 4559m and 250 
again after two days at this altitude. They observed a non-significant increase in both 251 
central and peripheral SBP but an even greater and significant increase in DBP.  AI@75 252 
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significantly increased from Sea level to HA. However, whereas the SBP continued to 253 
increase from 4-6 hours to two days at HA there was no further increase in the AI@75 254 
beyond the early increase. In our study we noted a similar sized increase in both brachial 255 
and central SBP to that in this previous study and the significance in our current study 256 
likely relate to our much larger sample size. Our data would seem to suggest that the 257 
increase in heart rate is a significant independent predictor of the increase in AI at HA 258 
which was not directly related to either the SpO2 or altitude. The observed increase in heart 259 
rate, AI, brachial and central SBP would strongly suggest that these increases relate to 260 
sustained sympathetic activation at HA as has been well described rather than a genuine 261 
increase in large artery stiffness.23  262 
 In one of the only previously published studies to assess the effects of HA on 263 
arterial stiffness and brachial BP during a conventional trek Rhodes et al studied 17 264 
subjects over an ascent from 80m to 4770m over 11 days.6 They found that HA led to a 265 
transient increase in large artery stiffness index (using finger photoplethysmography) noted 266 
at day four at 3450 m before returning to baseline levels. A significant rise in both systolic 267 
and diastolic BP were observed at 3450m and the increase was sustained throughout the 268 
HA exposure.6 Interestingly, they observed that the increase in BP was not related to 269 
changes in arterial stiffness nor was there a link between the increase in arterial tone and 270 
the presence of AMS. We did not identify a relationship between LLS, SpO2 and either AI, 271 
which is an indirect measure of large artery stiffness and central systolic BP at HA.   272 
 Consistent with previous research we found that the AI related to the 273 
subjects age and inversely correlated with height and heart rate.27,28 This is explained by 274 
the fact that the time of the reflected wave is related to the dimensions of the body and 275 
heart rate. In shorter individuals, a reduced return time for reflected waves leads to an 276 
increase in central pressure augmentation.27 As a result of the noted influence of heart rate 277 
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on AI it has been suggested that AI should be adjusted for the effects of heart rate and this 278 
has traditionally been to an average of 75 per minute (AI@75).29 Adjusting the AI@75 to 279 
account for heart rate did not alter our findings. It has also been more recently suggested 280 
that adjusting for heart rate on multivariate analysis of AI is more appropriate and this has 281 
been additionally done in our analysis.30 Our data has shown that heart rate was the 282 
independent variable with the greatest impact on AI. Indeed augmentation of central BP is 283 
influenced by heart rate and therefore the duration of systole and shifting the reflected 284 
arterial wave to diastole and reducing the time to wave reflection as has been observed in 285 
our study.29 Therefore it is reasonable to assume that the increase in AI at HA is largely 286 
related to the associated increase in heart rate leading to a rise in arterial augmentation and 287 
central BP rather than actual changes in large artery stiffness over only 14 days HA 288 
exposure.  289 
In this study we were also interested in the effects of HA on the ssPPV. This is a 290 
measure of the variation in the pulse pressure averaged over the 10 second arterial 291 
waveform recording using the BP+ device.  The beat to beat variation in pulse pressure is 292 
known be influenced by a number of factors including left ventricular preload, stroke 293 
volume and ventilation, which are all known to be affected at HA.22 Clinically, probably 294 
the most widespread use of ssPPV has been to assess fluid responsiveness in mechanically 295 
ventilated patients intra-operatively and on intensive care.20,21 During inspiration negative 296 
intrathoracic pressure leads to an increase in venous return and ultimately an increase in 297 
ventricular filling. Its effect on left ventricular stroke volume is influenced by hydration 298 
and intravascular filling, which is dependent on the relative position on the Frank-Starling 299 
curve.19HA-related hypoxia has been shown to affect both right and left ventricular stroke 300 
volume with variable effects on ventricular filling.4.22.25 The mechanisms to explain these 301 
changes are complex and include the known hypoxia mediated pulmonary vasoconstriction 302 
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leading to an increase in pulmonary artery systolic pressure and right ventricular afterload.5 303 
HA acclimatisation is known to lead to relative dehydration and hypoxia-mediated 304 
hyperventilation all of which may affect biventriuclar ventricular  stroke volume. Whilst 305 
the ssPPV cannot be used in isolation serial measurements can be used to assess filling and 306 
fluid responsiveness. In our study the ssPPV was very susceptible to the effects of HA 307 
exposure but was not related to LLS. HA led to a marked increase in the ssPPV, despite no 308 
significant increase in the central arterial pulse pressure.  309 
This study has a number of limitations that require acknowledgement. The subjects 310 
were studied in groups two days apart. This was done to accommodate the large sample 311 
size of the study and ensure excellent reproducibility of the measures and ensure that 312 
subject BP measurements were conducted robustly at each individual research station by 313 
trained researchers. The environmental factors, such as temperature and barometric 314 
pressure would not have been identical for the study groups at the time of their data 315 
collection which could have potentially influenced the findings. However, we did not 316 
observe any significant influence of the trekking group order of study on either AI or 317 
central systolic blood pressure. Unfortunately, we did not measure hormonal markers of 318 
sympathetic activation, such as circulating catecholamines, to better investigate the 319 
mechanism for the increase in SBP and AI, however, we did note that the increases did not 320 
relate to the degree of hypoxia (SpO2) or LLS. 321 
 322 
In conclusion in this study we found that HA exposure led to an increase in brachial and 323 
central SBP and a rise in AI compared with near sea level baseline levels. The increase in 324 
central SBP and AI was not related to the degree of hypoxia and SpO2 at HA nor to LLS. 325 
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The observed changes likely relate to increased sympathetic activation rather than any 326 
genuine change in large artery stiffness.  327 
 328 
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What is known about the topic?  338 
●  HA exposure leads to an increase in heart rate and there is evidence from a single study 339 
of rapid largely cable car ascent to 4559m that it leads to an increase in central SBP and 340 
arterial AI.  341 
 342 
What this study adds?  343 
●  This is the first study to examine the effects of stepwise increasing terrestrial HA on 344 
arterial stiffness and central BP over a conventional and progressive HA trek to 345 
>5000m. 346 
• We have discovered that the HA exposure led to a significant increase in central SBP 347 
and AI.  348 
• Neither altitude nor the SpO2 were independent predictors of AI and central SBP. 349 
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• The increase in AI related to the increase in heart rate at HA and did not reflect a 350 
genuine change in large artery stiffness.  351 
  352 
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Legends for Figures 447 
 448 
Figure 1Ascent Profile the altitude and timing of data collection  449 
Figure 2 Changes in systolic blood pressure with HA exposure. Symbol* denotes 450 
significant difference vs baseline level   451 
Figure 3 Change in Augmentation Index with high altitude 452 
Table 1: Baseline Demographics  
Demographic Result  
Age, years (range)  32.2±8.7 (18-56) 
Males n, % 63 (70%) 
Height, cm 173.5±9.1  
Weight, kg 73.4±12.3 
Body mass index kg/m2 24.38±2.7 
Ethnicity, % 
- Caucasian  
- Nepalese  
- South Asian 
 
78 (86.7%) 
11 (12.2%) 
1 (1.1%) 
Smoking status (N, %) 
- Current  
- Ex  
- Never 
 
9 (10%) 
11 (12.2%) 
70 (77.8%) 
 
Table 2 Effect of high altitude on measured vascular parameters including central blood 
pressure and augmentation index 
Parameter Sea level 3619m 4600m 5140m P value 
Heart rate/ minute 65.2±12.8 69.6±11.8 77.3±15.3 78.2±13.6 <0.0001*†‡ 
Oxygen Saturations, % 97.7±1.4† 91.9±3.4 82.8±6.3 80.4±5.3 <0.0001*†‡ 
Lake louis Scores 0.23 (0.64) 1.1 (1.9) 1.4 (1.6) 1.3 (1.4) <0.0001*†‡ 
Brachial artery  
systolic BP, mmHg 
132.8±14.0 136.9±13.4 138.8±13.3 138.6±13.9 0.04†‡ 
Brachial artery diastolic 
BP, mmHg 
81.8±11.7 84.7±9.4 83.7±9.8 83.9±9.7 0.28 
Mean brachial arterial 
BP, mmHg 
99.3±12.9 102.0±9.9 102.1±9.9 102.2±9.8 0.23 
Brachial artery pulse 
pressure, mmHg 
51.6±11.3 52.1±9.7 55.5±10.9 54.7±11.3 0.02† 
Central systolic BP, 
mmHg 
124.7±14.8 130.1±14.2 131.4±15.4 129.4±14.3 0.02*†‡ 
Central diastolic BP, 
mmHg 
84.0±11.6 87.5±9.6 86.8±9.6 87.3±9.5 0.09 
Central artery pulse 
pressure, mmHg 
40.7±9.5 42.6±9.6 44.6±13.4 42.1±9.9 0.26 
Augmentation  
index, % 
55.3±34.9 71.1±34.1 61.8±36.7 56.6±32.7 0.001† 
Reflected wave transit 
time, s 
0.16±0.02 0.16±0.02 0.14±0.02 0.14±0.01 <0.000*†‡ 
Systolic ejection period, s 0.30±0.03 0.31±0.02 0.29±0.03 0.28±0.02 <0.0001†‡ 
Supra Systolic pulse 
pressure variation 
0.23±0.13 0.28±0.15 0.37±0.20 0.34±0.19 <0.0001*†‡ 
BP, blood pressure; results of post hoc tests vs baseline sea level,  *3880m, † 4400m, ‡ 5140m 
 



